X4 Pharmaceuticals, Inc.XFORNASDAQ
Loading
Net Income ContractionContracting
Percentile Rank30
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Latest
$-79.20M
↓ 28% vs avg
Percentile
P30
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-61.90M
Historical baseline
PeriodValueYoY Change
TTM$-79.20M-111.5%
2024$-37.45M+63.0%
2023$-101.17M-7.8%
2022$-93.87M-5.8%
2021$-88.70M-42.8%
2020$-62.13M-9.8%
2019$-56.60M-31.6%
2018$-43.02M-27.0%
2017$-33.88M-47.5%
2016$-22.98M-